v.nascimento
TL2 Moderator · Dijon
Contributes reviews on supplier material. Based in Dijon.
Joined 19 October 2024 · last posted 10h
81 posts, newest first. Showing up to 150.
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #101 · Access › Insurance & coverage · 27 Jul 2026 · 0 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
Insomnia at a dose step: reported experiences — the long version Replied, post #51 · Wellbeing › Sleep · 24 Jul 2026 · 22 likes post #50 is right about the mechanism and I think understates the practical bit. Obstructive sleep apnoea: pre-existing OSA can worsen with weight before it improves…
-
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #46 · Compounds › Retatrutide · 22 Jul 2026 · 0 likes Coming back to post #44, because the follow-up matters more than the original answer. Glucagon receptor agonism seems paradoxical in a weight-loss compound because…
-
Coming back to: Payment method and the leverage it gives you, ranked Replied, post #21 · Sourcing › Payments · 16 Jul 2026 · 1 like Coming back to post #19, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
How much context is too much context in a first post? Replied, post #71 · Start Here › How to Ask · 10 Jul 2026 · 5 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Insurance and replacement policies, compared Replied, post #72 · Sourcing › Logistics · 8 Jul 2026 · 3 likes Reshipment after seizure: if a parcel is seized, some suppliers will reship; others will not. That is a supplier choice and should be understood before ordering in a…
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #38 · Pharmacology › Pharmacokinetics · 30 Jun 2026 · 0 likes Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments…
-
Angle of injection and whether 90 degrees is always right — the long version Replied, post #27 · Practice › Administration · 19 Jun 2026 · 27 likes Coming back to post #25, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Revisiting: The best-written scientific paper you have read Replied, post #39 · Lounge › Off topic · 18 Jun 2026 · 9 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Reading a trial's population section before its results Replied, post #107 · Evidence › Trials · 10 Jun 2026 · 0 likes Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a stand-in. HbA1c is a surrogate for long-term glucose control and the…
-
Racemisation and why it is invisible to a mass measurement Replied, post #7 · Analytics › Impurities & related substances · 8 Jun 2026 · 19 likes Picking up post #4: that is the part I would want checked first. Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #88 · Practice › Storage & stability · 8 Jun 2026 · 0 likes I read post #86 twice before replying, because I had assumed the opposite. Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #71 · Evidence › Journal club · 30 May 2026 · 0 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Peak-to-trough ratio at steady state for a weekly agent Replied, post #2 · marked as the solution · Pharmacology › Pharmacokinetics · 29 May 2026 · 7 likes Coming back to the opening post, because the follow-up matters more than the original answer. Renal clearance: these compounds are cleared partly via the kidney. In…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #23 · Analytics › Method validation · 29 May 2026 · 6 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #31 · Analytics › Home & field testing · 25 May 2026 · 6 likes Coming back to post #29, because the follow-up matters more than the original answer. Why third-party testing is stronger: a home test run by the person who made the…
-
Reading a trial's population section before its results Replied, post #49 · Evidence › Trials · 24 May 2026 · 29 likes Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug. Per-protocol includes only those who completed it as…
-
Blind submission and why it changes minds — the long version Replied, post #86 · Sourcing › Independent verification · 20 May 2026 · 4 likes On post #82 — agreed on the reasoning, with one qualification. PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both…
-
Bariatric surgery history: altered anatomy, altered expectations Replied, post #8 · Clinical › Special populations · 13 May 2026 · 0 likes Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #138 · Pharmacology › Pharmacokinetics · 11 May 2026 · 30 likes I read post #136 twice before replying, because I had assumed the opposite. SNAC (the oral bioavailability enhancer): sodium N-(8-[2-hydroxybenzoyl]amino) caprylate…
-
Five questions in one post gets you one answer — how to split them Replied, post #75 · Start Here › How to Ask · 8 May 2026 · 0 likes Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and I get this number for the syringe mark" is answerable. "How…
-
Journal club: is percentage weight change the right endpoint? Replied, post #116 · Evidence › Journal club · 29 Apr 2026 · 26 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #82 · Evidence › Study critique · 24 Feb 2026 · 0 likes Picking up post #79: that is the part I would want checked first. Criticise the method, not the author: a paper with a weak design is not a bad paper by someone with…
-
Follow-up: I have no scientific background — can I still follow the analytics categories? Started this topic · Start Here › Welcome · 17 Feb 2026 · 24 likes Asking directly, because I could not find a straight answer: I have no scientific background — can I still follow the analytics categories? Question in the title.…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #13 · Start Here › Welcome · 14 Feb 2026 · 0 likes The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it is well indexed for the questions that come up most.
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #41 · Practice › Interactions · 29 Jan 2026 · 0 likes Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
-
A plateau that disappeared when I changed how I measured — the long version Replied, post #4 · Outcomes › Progress reports · 29 Jan 2026 · 0 likes Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition and activity changes might contribute. Noting the season is useful…
-
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #40 · Devices › Pens & autoinjectors · 28 Jan 2026 · 0 likes Off-label dosing with a pen: if you want to deliver a dose different from the pen's pre-set steps (e.g., halfway between two step doses), that is off-label use. Some…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #86 · Clinical › Special populations · 27 Jan 2026 · 14 likes Disordered eating history: a history of anorexia nervosa, bulimia, or other eating disorders changes the risk-benefit calculation because appetite suppression might…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #65 · Clinical › Special populations · 24 Jan 2026 · 6 likes Worth separating two things that post #61 runs together. Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #97 · Compounds › Oral incretins · 18 Dec 2025 · 3 likes Why an oral formulation is a formulation achievement: the molecule is the same but the tablet is novel. Getting a peptide across the gastric epithelium at usable…
-
[2026 update] Conference abstracts as evidence: the weakest common citation Replied, post #2 · Evidence › Preprints · 13 Dec 2025 · 3 likes Do not build anything on a preprint that you would mind rebuilding: if the preprint later changes substantially in revision or shows different results when published,…
-
DXA precision and the least significant change for lean mass Replied, post #56 · Outcomes › Body composition · 9 Dec 2025 · 17 likes Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary around that mean. Being above or below average is not a sign…
-
Tracking a preprint to publication: a worked example Replied, post #86 · Evidence › Preprints · 8 Dec 2025 · 0 likes How to cite a preprint: author last name, first initial, et al. Title. Server name [preprint]. Posted date. Doi. Include the server name and note that it is a preprint.
-
Run-in periods and the population they select Replied, post #32 · Evidence › Trials · 7 Dec 2025 · 7 likes This follows post #29 rather than contradicting it. Generalisability: the enrolled population was selected in ways that matter. Entry criteria, run-in periods, and the…
-
Reading SURMOUNT-1 without the press release Replied, post #89 · Compounds › Tirzepatide · 4 Dec 2025 · 0 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
Cross-border purchase rules within the EU Replied, post #48 · Regional › European Union · 2 Dec 2025 · 0 likes Private prescription with self-payment is legal across the EU and is the common route where public reimbursement is not available.
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #68 · Compounds › Other compounds · 25 Nov 2025 · 30 likes Coming back to post #66, because the follow-up matters more than the original answer. Research-use-only status is a legal classification, not a safety classification.…
-
Lurking for two months before posting: was that the right call? Replied, post #64 · Start Here › Welcome · 20 Nov 2025 · 29 likes Coming back to post #62, because the follow-up matters more than the original answer. The moderation log is public. Every staff action is logged with the rule cited and…
-
Pen dose counters: what a click does and does not guarantee Replied, post #112 · Devices › Pens & autoinjectors · 19 Nov 2025 · 8 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Long-time reader, first-time poster Replied, post #5 · Lounge › Introductions · 4 Nov 2025 · 24 likes Picking up post #2: that is the part I would want checked first. Privacy: share only what you are comfortable making permanent and public. An introduction is archived…
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #82 · Sourcing › Vendor reports · 30 Oct 2025 · 12 likes Temporal patterns: if results from a supplier were good two years ago but have deteriorated recently, that is information. If they have been consistent over years, that…
-
Trust level 3 requirements: a clarification Replied, post #14 · Meta › Announcements · 29 Oct 2025 · 17 likes Worth separating two things that post #10 runs together. Staff-only posts: some announcements are visible only to staff (concerning internal operations). Members see…
-
Second pass at: Programming during a large energy deficit Replied, post #58 · Nutrition & Training › Resistance training · 29 Oct 2025 · 16 likes Post-weight-loss training: once weight loss is complete and energy deficit ends, training can shift to building again. The transition from preservation mode to building…
-
Compounds this community declines to help with, and why Replied, post #86 · Compounds › Other compounds · 8 Oct 2025 · 6 likes Distinguishing marketed research compounds from true chemical synthesis: some online suppliers sell compounds that are genuinely novel and difficult to obtain…
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #73 · Compounds › Cagrilintide & amylin analogues · 4 Oct 2025 · 0 likes Cagrilintide alone is discussed less than in combination because the published data is almost entirely from combination trials. The phase 2 combination data was…
-
Personal import allowances, compared — a second dataset Replied, post #5 · Access › International · 1 Oct 2025 · 0 likes I read post #3 twice before replying, because I had assumed the opposite. Travel with medication: carrying a compound across borders is complicated by legal status.…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #82 · Practice › Administration · 27 Sep 2025 · 6 likes Picking up post #79: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
Substitution between formats during a shortage Replied, post #62 · Access › Shortages · 23 Sep 2025 · 0 likes International supply chains: a shortage in one country does not mean shortage in another. That is why ordering from multiple suppliers before a shortage gets bad is…
-
Titles that describe the question, not the situation — what changed since Replied, post #25 · Start Here › How to Ask · 18 Sep 2025 · 0 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
Research-use-only labelling: what it means and what it does not Replied, post #34 · Sourcing › Regulatory · 16 Sep 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #4 · Analytics › Home & field testing · 30 Aug 2025 · 0 likes Worth separating two things that the opening post runs together. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Follow-up: Sodium, potassium and magnesium when intake drops Replied, post #2 · Nutrition & Training › Hydration & electrolytes · 13 Aug 2025 · 0 likes Water intoxication: drinking excessive water (more than a few liters per day for extended time) without electrolyte replacement can cause hyponatremia. This is rare but…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #110 · Practice › Storage & stability · 11 Aug 2025 · 0 likes Protecting from light: amber vials or opaque containers reduce light exposure. If you are storing for long periods and light matters, this is worth doing. For…
-
Pooling trials with different estimands — what changed since Replied, post #11 · Evidence › Meta-analyses · 8 Aug 2025 · 20 likes Fixed-effects versus random-effects models: fixed-effects assumes all studies are estimating the same thing and variation is sampling error. Random-effects assumes…
-
How to research a compound with no human data without deceiving yourself Replied, post #49 · Compounds › Other compounds · 1 Aug 2025 · 0 likes This follows post #46 rather than contradicting it. When "no data" is the complete and final answer: if there is no published human data on a compound, that is the…
-
High-resolution MS on aggregates and what it can see Replied, post #22 · Analytics › Mass spectrometry · 13 Jul 2025 · 14 likes I read post #20 twice before replying, because I had assumed the opposite. Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS,…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #72 · Compounds › Other compounds · 28 Jun 2025 · 1 like I read post #70 twice before replying, because I had assumed the opposite. AOD-9604 is a fragment of human growth hormone and has been discussed as a potential…
-
Repeatability versus intermediate precision Replied, post #29 · Analytics › Method validation · 21 Jun 2025 · 5 likes Coming back to post #27, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Pre-registering a personal experiment, seriously Replied, post #70 · Research Methods › N-of-1 designs · 31 May 2025 · 5 likes Statistical analysis of n-of-1 data: comparing before versus after with a t-test or similar is one approach. Plotting the data visually is another. Both are valid.
-
Retatrutide dose escalation in the published trials Replied, post #29 · Compounds › Retatrutide · 19 Mar 2025 · 0 likes This follows post #26 rather than contradicting it. What we do not know about retatrutide, listed explicitly: long-term safety, real-world response rates, the dose…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #29 · Access › Pricing · 10 Mar 2025 · 8 likes On post #25 — agreed on the reasoning, with one qualification. Two things before anyone answers the substance. First, the context in the first post is clear and…
-
Preservatives: function, testing, and limits Replied, post #17 · Pharmacology › Formulation chemistry · 6 Mar 2025 · 9 likes post #16 answers the question as asked. The question underneath it is different. Isotonicity: an isotonic solution has the same osmotic pressure as blood. Non-isotonic…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #62 · Devices › Cold chain · 5 Mar 2025 · 11 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #71 · Compounds › Secretagogues & GH axis · 5 Feb 2025 · 0 likes IGF-1 as a surrogate: it is a better integrated measure than a spot growth hormone level and it is still a surrogate, with all the caveats that come with surrogates.…
-
A promotion I argued against, and why I lost Replied, post #79 · Documentation › Doc review · 30 Jan 2025 · 23 likes New maintainer recruitment: if a page's maintainer is inactive and updates are needed, suggesting a new maintainer here can help transition responsibility.
-
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #26 · Compounds › Oral incretins · 29 Jan 2025 · 0 likes post #25 answers the question as asked. The question underneath it is different. The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type…
-
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #44 · Practice › Side effects · 23 Jan 2025 · 16 likes Gallbladder complications: rapid weight loss increases the risk of gallstone formation. The mechanism is not specific to this drug class. The risk is greatest in the…
-
Oxidation pathways for methionine and tryptophan Replied, post #56 · Analytics › Impurities & related substances · 30 Dec 2024 · 3 likes Picking up post #53: that is the part I would want checked first. Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double…
-
Scheduled maintenance and what will be unavailable Replied, post #2 · Meta › Announcements · 25 Dec 2024 · 2 likes When announcements are made: major policy changes, technical changes affecting site function, planned downtime, and changes to guidelines all get announced here.
-
[2026 update] How to read a forest plot, properly, from scratch Replied, post #2 · Evidence › Trials · 24 Nov 2024 · 0 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
Turnaround times and what they mean for a decision — one year on Replied, post #14 · Sourcing › Independent verification · 15 Nov 2024 · 17 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #92 · Clinical › Prescriber conversations · 4 Nov 2024 · 0 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #9 · Evidence › Journal club · 1 Nov 2024 · 0 likes SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome trial in people without diabetes, which decoupled the cardiovascular…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #118 · Access › Shortages · 13 Oct 2024 · 21 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Hypertension improvement and when medication needs revisiting — a second dataset Replied, post #27 · Clinical › Comorbidities · 13 Oct 2024 · 0 likes Hepatic steatosis and MASH: a phase 2 trial in semaglutide for steatohepatitis showed resolution was more frequent on treatment. Histological resolution is a surrogate…
-
US compounding rules and how they changed Started this topic · Regional › North America · 23 Sep 2024 · 12 likes US compounding rules and how they changed — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included,…
-
Circumference measurements as a poor man's composition estimate Replied, post #29 · Outcomes › Body composition · 30 Jul 2024 · 7 likes Picking up post #26: that is the part I would want checked first. Comparison to published data: the trials reported mean fat and lean mass changes. Individual results…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #20 · Compounds › Retatrutide · 17 Jul 2024 · 1 like Coming back to post #18, because the follow-up matters more than the original answer. Triple agonism: is the effect additive, synergistic, or neither? A phase 2…
-
How this community labels and discusses unrefereed work Replied, post #41 · Evidence › Preprints · 26 Jun 2024 · 21 likes Peer review as a filter: published papers have survived a review process that rejects many submissions. Preprints have not. Neither guarantees correctness, but…
-
The mass-error checker and its intended scope Replied, post #7 · Data & Tools › Calculators · 22 May 2024 · 1 like I read post #5 twice before replying, because I had assumed the opposite. Dose equivalence calculator: compounds have different potencies. The calculator is provided…